The management team at Vigilant Diagnostics has decades of experience in the medical technology and diagnostics industries, and in managing startup and emerging growth companies. Together, they share a vision to improve healthcare through faster and more accurate diagnoses of infectious diseases globally, while reducing the economic and cultural burden of such diseases on society.
Richard C. Carlson – Co-CEO & Board Member
Rick has a proven track record as a team builder, mentor, communicator, fundraiser, and value creator with extensive experience with global medtech companies and early-stage startups. He is a successful entrepreneur and has extensive international experience in marketing, business development, sales, customer service, and operations. He previously served in senior executive roles for Medtronic, Boston Scientific, Surmodics, CR Bard, American Medical Systems, and others. Rick holds an MBA from the Carlson School of Management and serves as an advisor for the University of Minnesota’s Office for Technology Commercialization.
Frank F. Jiang, MD, PhD – Co-CEO & Board Member
Dr. Jiang has 25 years of experience heading various medical technology firms. He has served on advisory boards for multinational medical device corporations and PE firms, including Medtronic, Johnson & Johnson, Bain Capital, CETIC Capital, and many developing medtech companies. He has also been a thoracic surgeon for 12 years. In addition, he has served as Executive Chairman and CEO of China Association for Medical Devices Industry (CAMDI). His experience includes establishing the largest medical device distribution system in China, which had annual sales of more than $200M USD. Dr. Jiang has founded nine device/pharma companies that exited through acquisition. He has offices in NY, Beijing, and Amsterdam.
James Sackrison – CTO & Board Member
Jim is a clinical chemistry pioneer and key opinion leader in the in vitro diagnostic space, including 15 years at Beckman Coulter (a Danaher Company), a leading global diagnostics firm, and more recently as an independent consultant. At Beckman Coulter, he served as Principal Scientist and was a five-time winner of the company’s Excellence in Innovation Award. Jim has had more than 50 diagnostic assays approved through the FDA, and has been highly successful at transforming multiple technical opportunities into cost-effective business solutions. He enjoys bringing together diverse stakeholders to build sustainable solutions for new and challenging issues.
John C. Bischof, PhD – Founder & Board Member
Dr. Bischof has been the principal investigator and chief scientific officer of Vigilant Diagnostics since its founding in 2014. He is the Distinguished McKnight Professor of Mechanical and Biomedical Engineering at the University of Minnesota, and is also the Carl and Janet Kuhrmeyer chair in Mechanical Engineering. More recently, he was appointed Director of the University’s Institute for Engineering in Medicine, which is dedicated to advancing healthcare by strengthening research collaborations between engineering and medicine in both academia and industry. He has been cited more than 10,000 times and authored 230+ papers in the fields of therapeutics, regenerative medicine, and diagnostics.
Warren C. W. Chan, PhD – Cofounder & Board Member
Dr. Chan is an internationally renowned researcher in diagnostics and immunoassays. He is Professor, Institute of Biomaterials and Biomedical Engineering, and the Canadian Research Chair in Bionanotechnology, at the University of Toronto, and has been cited more than 50,000 times and authored 100+ papers, many in the fields of cancer nanotechnology and diagnostics. He works closely with Dr. Bischof and a group of world-class scientists and physicians serving as advisors to the company, all of whom share his devotion to advancing diagnostics and eradicating major, global infectious diseases such as Malaria, HIV, Meningitis, Influenza, and COVID-19.
Paul Gramstad, CPA – Financial Officer
Paul is an experienced executive with extensive financial and operations expertise, including with several emerging startup companies. He is a creative thinker who has enjoyed success in a wide range of industries such as medical technology, nanomaterials, software, ecommerce, and energy. Paul is adept at managing day-to-day accounting and administrative operations, and providing strategic financial leadership. He is well known as a problem solver and team player, working well with all levels of an organization in order to achieve company goals.
Ready to find out more?
Drop us a line today!